Psilocybin-Assisted Therapy in Treatment-Resistant Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Psilocybin-Assisted Therapy in Treatment-Resistant Depression — Stella

Recruiting

Back to Refractory Depression trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

UNC Chapel Hill Medical Center, Chapel Hill, North Carolina

Key details

Phase

Large-scale testing

Sponsor

University of North Carolina, Chapel Hill

Collaborators

Foundation of Hope, North Carolina

Enrollment target

~23 participants

Started

April 2024

Primary completion

June 2026

Age range

18 Years – 70 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov